Salarius Pharmaceuticals Inc (SLRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 3,465 | 1,951 | 1,275 | 1,011 | 0 |
| Cost of Goods | N/A | N/A | 507 | 663 | N/A |
| Gross Profit | 3,465 | 1,951 | 768 | 348 | N/A |
| Operating Expenses | 11,730 | 3,636 | 36,000 | 40,897 | 29,214 |
| Operating Income | -8,265 | -1,685 | -34,726 | -39,886 | -29,214 |
| Other Income | 1,329 | 15 | 292 | 393 | 72 |
| Pre-tax Income | -6,936 | -1,670 | -34,434 | -39,493 | -29,142 |
| Net Income Continuous | -6,936 | -1,670 | -34,434 | -39,493 | -29,142 |
| Net Income | $-6,936 | $-1,670 | $-34,434 | $-39,493 | $-29,142 |
| EPS Basic Total Ops | -6,356.82 | -3,478.26 | -149,175.40 | -182,158.90 | -155,922.00 |
| EPS Basic Continuous Ops | -6,363.02 | -3,253.03 | -149,544.60 | -182,364.60 | -155,671.90 |
| EPS Diluted Total Ops | -6,356.82 | -3,478.26 | -149,175.40 | -182,158.90 | -155,922.00 |
| EPS Diluted Continuous Ops | -6,363.02 | -3,253.03 | -149,544.60 | -182,364.60 | -155,671.90 |
| EPS Diluted Before Non-Recurring Items | -6,356.82 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-8,138 | $-1,668 | $-34,469 | $-39,593 | $-29,154 |